These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection. Visser R; de Mast Q; Munnix I; van der Ven A; Dofferhoff T Travel Med Infect Dis; 2016; 14(6):644-645. PubMed ID: 27546283 [No Abstract] [Full Text] [Related]
3. Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb. Teo BH; Lansdell P; Smith V; Blaze M; Nolder D; Beshir KB; Chiodini PL; Cao J; Färnert A; Sutherland CJ PLoS Negl Trop Dis; 2015; 9(10):e0004068. PubMed ID: 26485258 [TBL] [Abstract][Full Text] [Related]
4. Recrudescing Plasmodium malariae infection despite appropriate treatment in an immigrant toddler. Islam S; Hai F Paediatr Int Child Health; 2018 Nov; 38(4):290-293. PubMed ID: 28975859 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark. Kofoed K; Petersen E J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688 [TBL] [Abstract][Full Text] [Related]
6. Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria. Radloff PD; Philipps J; Hutchinson D; Kremsner PG Trans R Soc Trop Med Hyg; 1996; 90(6):682. PubMed ID: 9015517 [No Abstract] [Full Text] [Related]
7. A case of Plasmodium malariae recurrence: recrudescence or reinfection? Grande R; Antinori S; Meroni L; Menegon M; Severini C Malar J; 2019 May; 18(1):169. PubMed ID: 31088460 [TBL] [Abstract][Full Text] [Related]
8. A case of imported Plasmodium malariae malaria. Hong YJ; Yang SY; Lee K; Kim TS; Kim HB; Park KU; Song J; Kim EC Ann Lab Med; 2012 May; 32(3):229-33. PubMed ID: 22563561 [TBL] [Abstract][Full Text] [Related]
9. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K; Scott L Drugs; 2003; 63(6):597-623. PubMed ID: 12656656 [TBL] [Abstract][Full Text] [Related]
10. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil. Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL Malar J; 2008 Nov; 7():240. PubMed ID: 19021900 [TBL] [Abstract][Full Text] [Related]
11. Plasmodium malariae in Israeli Travelers: A Nationwide Study. Yavne Y; Leshem E; Paran Y; Nadir E; Weinberger M; Stein M; Petersiel N; Yahav D; Grossman T; Schwartz E Clin Infect Dis; 2017 Oct; 65(9):1516-1522. PubMed ID: 29020345 [TBL] [Abstract][Full Text] [Related]
13. Problems in the therapy of mixed malarial infections: a case of infection with Plasmodium falciparum and P. malariae treated with mefloquine and halofantrine. Hess FJ; Kilian HD; Nothdurft HD; Löscher T Trans R Soc Trop Med Hyg; 1993; 87(6):688. PubMed ID: 8296379 [No Abstract] [Full Text] [Related]
14. Atovaquone and proguanil hydrochloride: a review of nonclinical studies. Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546 [TBL] [Abstract][Full Text] [Related]